Medical Journal Urges Glaxo To Reveal Trial Results

A leading medical journal urged drugs giant GlaxoSmithKline on Friday to reveal all its research on the antidepressant Seroxat, which has been the subject of controversy on both sides of the Atlantic because of a possible increased risk of suicidal behavior in young patients. New York Attorney General Eliot Spitzer filed a suit last week, claiming Europe's largest drugmaker withheld negative information about treating children and teenagers with the drug, which is also known as paroxetine and sold in the United States under the name Paxil.

Back to news